Don’t miss the Canadian Cancer Survivor Network’s next webinar on cancer-associated blood clots!
Every year there are 30,000 incidences of cancer-associated thrombosis (CAT) in Canada, with approximately 20 to 25 percent of the more than 200,000 Canadians diagnosed with cancer developing blood clots at some point during their cancer treatment. For patients already dealing with cancer, the effects of blood clots, both in terms of quality of life and long-term survival, can be devastating.
The presentation will be followed by an interactive discussion with participants.
Can’t attend? Be sure to register in order to have a copy of the slides as well as a YouTube recording of the webinar sent to you.
Dr. Peter L. Gross obtained his MSc in Biochemistry and his MD from the University of Toronto. He did his Core Internal Medicine training in Toronto. He did his Hematology/Oncology Fellowship at Beth Israel Deaconess Medical Center, a Harvard Teaching Hospital. He was Clinician Scientist in the Department of Medicine at St Michael’s Hospital in Toronto from 2003 to 2007. He is currently an Associate Professor in the Division of Hematology and Thromboembolism at McMaster University, Hamilton and the Thrombosis Clinic Director at the Juravinski Hospital and Cancer Centre.
Dr. Gross’s basic science laboratory at the Thrombosis and Atherosclerosis Research Institute (TaARI) focuses on models of thrombosis and hemostasis, and biomarkers for these conditions. Dr. Gross is also is involved in various capacities in clinical trials in venous thrombosis. He is also a member of the Canadian Hemophilia Foundation Research Advisory Board.
To register for the webinar, please click here.